{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "JOUNCE THERAP. DL-,001", "longName": "Jounce Therapeutics, Inc.", "messageBoardId": "finmb_228489698", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.67, "marketState": "REGULAR", "fiftyTwoWeekLowChange": 1.1378, "fiftyTwoWeekLowChangePercent": 2.1379182, "fiftyTwoWeekRange": "0.5322 - 4.73", "fiftyTwoWeekHighChange": -3.06, "fiftyTwoWeekHighChangePercent": -0.64693445, "fiftyTwoWeekLow": 0.5322, "fiftyTwoWeekHigh": 4.73, "earningsTimestamp": 1678458120, "earningsTimestampStart": 1690979400, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.87, "epsForward": -2.0, "epsCurrentYear": -1.39, "priceEpsCurrentYear": -1.2014388, "sharesOutstanding": 52635500, "bookValue": 3.542, "fiftyDayAverage": 1.41286, "fiftyDayAverageChange": 0.25713992, "fiftyDayAverageChangePercent": 0.18199956, "twoHundredDayAverage": 1.875022, "twoHundredDayAverageChange": -0.2050221, "twoHundredDayAverageChangePercent": -0.109343834, "marketCap": 89404616, "forwardPE": -0.835, "priceToBook": 0.47148502, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.4 - Buy", "priceHint": 4, "regularMarketChange": 0.0, "regularMarketTime": 1683184121, "regularMarketDayHigh": 1.67, "regularMarketDayRange": "1.67 - 1.67", "regularMarketDayLow": 1.67, "regularMarketVolume": 5300, "regularMarketPreviousClose": 1.67, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.67, "averageDailyVolume3Month": 452, "averageDailyVolume10Day": 820, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1486018800000, "symbol": "21J.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "780 Memorial Drive", "city": "Cambridge", "state": "MA", "zip": "02139", "country": "United States", "phone": "857 259 3840", "fax": "888 459 2940", "website": "https://jouncetx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. It develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. The company is also developing JTX-8064, a monoclonal antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; and Pimivalimab, an anti-PD-1 antibody for combination therapy. In addition, its preclinical products are JTX-1484, a monoclonal antibody designed to reduce myeloid-mediated immune suppression; and JTX-2134, a monoclonal antibody designed to reduce myeloid-mediated immune suppression and activate T and NK cells. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. As of May 3, 2023, Jounce Therapeutics, Inc. operates as a subsidiary of Concentra Biosciences, LLC.", "fullTimeEmployees": 141, "companyOfficers": [{"maxAge": 1, "name": "Ms. Kimberlee Cobleigh Drapkin C.P.A., CPA", "age": 54, "title": "Pres, CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2020, "totalPay": {"raw": 582388, "fmt": "582.39k", "longFmt": "582,388"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1132130, "fmt": "1.13M", "longFmt": "1,132,130"}}, {"maxAge": 1, "name": "Dr. James Patrick Allison Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Thomas F.  Gajewski M.D., Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert D. Schreiber Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Drew Mark Pardoll M.D., Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Padmanee  Sharma M.D., Ph.D.", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Louis M. Weiner M.D.", "age": 70, "title": "Founder", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Komal  Joshi", "title": "Head of Investor Relations & Strategic Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric  Laub", "title": "VP of Investor Relations, Corp. Communications & Media Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Minji  Kim", "title": "Head of Bus. Devel. & Alliance Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1609372800, "maxAge": 86400}}], "error": null}}